Malin Johansson, vice president Europe, HealthBeacon, discusses how its care management system assists patients and health care professionals managing chronic care treatment.
The COVID-19 pandemic has brought widespread impact to healthcare services worldwide and with it, significantly increased the need for patients and healthcare providers to assess and utilise innovative ways of interacting to optimising care in a new, ever changing health landscape.
Many patients that manage self-injecting medication for chronic conditions belong to COVID-19 high risk groups. It is essential to limit the contamination risk for these individuals and at the same time, more important than ever to follow treatment schedules to avoid unnecessary disease complications.
One of the major challenges for people self-injecting medication is adhering to treatment schedules. Non adherence causes both significant loss to patient health and a rapidly escalating financial burden on state health care systems across the globe. Evidence shows that, on average patients comply with their chronic medicine schedules only 50-60% of the time. However 80% - 90% compliance can be achieved when medicines are connected with adherence support solutions – which is where HealthBeacon steps in.
HealthBeacon’s Injection Care Management System removes the challenge for the patient to remember complicated treatment schedules. Now healthcare professionals can follow their patients in ‘real time’ and get immediate alerts if the patient struggles with adherence to the medication schedule or any other complication related to the treatment. HealthBeacon provides a personalised and effective support opportunity for the healthcare system by targeting the ‘high risk’ individuals that are in most need of support. This alone provides greater control and increases health outcomes for patients.
HealthBeacon´s vision is connecting people to better health through sustainable, digitally-enabled solutions. Together with health care providers and suppliers we help patient’s to better manage their chronic illnesses. We give patients’ insights to help them better understand their treatment and more frequently connect with their healthcare providers
By identifying, measuring data and understanding adherence patterns across multiple therapeutic areas and medicines, we enable preventative support models that identifies patients at risk, expands remote monitoring capabilities, increases patient-to-HCP interactions and touchpoints to improve delivery of care.
In direct response to the pandemic we have seen a spike in demand globally for remote support services from healthcare providers, highlighting the importance of remotely connected patient support. The service, has to date, been adopted by both pharmaceutical companies, governments, health insurance companies and individual healthcare providers.
We support patients across 14 different markets globally and most recently appointed as an official NHS supplier to provide remote monitoring technology platforms.
